Patent · US Active

Anti-PDGF-C antibodies

US9884910B2 · kind B2 · utility

8Cited by

10References

49Claims

0Family size

Assignee

ThromboGenics NV · BE

Inventors

Claudia Fromond · Paris, FR
Hoa Thu Ngo · Leuven, BE
Richard Zwaal · Gent, BE
Sofie Notebaert · Mortsel, BE

Key dates

Filing date	Apr 24, 2013
Grant date	Feb 6, 2018
Priority date	—
Expiry date	Apr 24, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to antibodies binding to the PDGF-C antigen and capable of inhibiting binding of PDGF-C to the PDGFRα receptor and of inhibiting PDGFRα activation by PDGF-C. Applications of such antibodies are also disclosed. These include treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.